UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization

Translational psychiatry, 2017-02, Vol.7 (2), p.e1024-e1024

2017

Volltextzugriff (PDF)

The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders

Molecular psychiatry, 2018-01, Vol.23 (1), p.59-69

2018

Volltextzugriff (PDF)

The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment

Molecular psychiatry, 2017-05, Vol.22 (5), p.666-679

2017

Volltextzugriff (PDF)

Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors

Psychological medicine, 2017-08, Vol.47 (11), p.1981-1989

2017

Volltextzugriff (PDF)

Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses

Psychological medicine, 2016-11, Vol.46 (15), p.3231-3240

2016

Volltextzugriff (PDF)

Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis

Molecular psychiatry, 2011-01, Vol.16 (1), p.67-75

2011

Volltextzugriff (PDF)

The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review

Translational psychiatry, 2017-01, Vol.7 (1), p.e1015-e1015

2017

Volltextzugriff (PDF)

The impact of severe mental illness (SMI) on the rate of COVID-19 vaccine uptake and hesitancy

European psychiatry, 2023-03, Vol.66 (S1), p.S454-S455

2023

Volltextzugriff (PDF)

From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments

Current pharmaceutical design, 2012-02, Vol.18 (4), p.459-465

2012

Volltextzugriff (PDF)

Making decisions about antipsychotics: a qualitative study of patient experience and the development of a decision aid

BMC psychiatry, 2019-10, Vol.19 (1), p.309-309, Article 309

2019

Volltextzugriff (PDF)

A comprehensive review and model of putative prodromal features of bipolar affective disorder

Psychological medicine, 2011-08, Vol.41 (8), p.1567-1577

2011

Volltextzugriff (PDF)

Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications

Psychopharmacology, 2016-05, Vol.233 (9), p.1605-1621

2016

Volltextzugriff (PDF)

The practical management of refractory schizophrenia - the Maudsley Treatment REview and Assessment Team service approach

Acta psychiatrica Scandinavica, 2014-12, Vol.130 (6), p.427-438

2014

Volltextzugriff (PDF)

Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging

Current pharmaceutical design, 2009-08, Vol.15 (22), p.2550-2559

2009

Volltextzugriff (PDF)

The Dopamine Hypothesis of Schizophrenia: Version III-The Final Common Pathway

Schizophrenia bulletin, 2009-05, Vol.35 (3), p.549-562

2009

Volltextzugriff (PDF)

Altered activation and connectivity in a hippocampal–basal ganglia–midbrain circuit during salience processing in subjects at ultra high risk for psychosis

Translational psychiatry, 2017-10, Vol.7 (10), p.e1245-e1245

2017

Volltextzugriff (PDF)

Fronto-limbic engagement during moral processing in stimulant users

Psychopharmacology, 2016-09, Vol.233 (17), p.3075-3076

2016

Volltextzugriff (PDF)

Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia

British journal of psychiatry, 2004-06, Vol.184 (6), p.503-508

2004

Volltextzugriff (PDF)

Striatal dopamine synthesis capacity in twins discordant for schizophrenia

Psychological medicine, 2011-11, Vol.41 (11), p.2331-2338

2011

Volltextzugriff (PDF)

Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia

Acta psychiatrica Scandinavica, 2018-01, Vol.137 (1), p.39-46

2018

Volltextzugriff (PDF)

Functional outcome in people at high risk for psychosis predicted by thalamic glutamate levels and prefronto-striatal activation

Schizophrenia bulletin, 2015-03, Vol.41 (2), p.429-439

2015

Volltextzugriff (PDF)

The Predictive Power of Brain mRNA Mappings for in vivo Protein Density: A Positron Emission Tomography Correlation Study

Journal of cerebral blood flow and metabolism, 2014-05, Vol.34 (5), p.827-835

2014

Volltextzugriff (PDF)

Presynaptic Dopaminergic Function: Implications for Understanding Treatment Response in Psychosis

CNS drugs, 2014-07, Vol.28 (7), p.649-663

2014

Volltextzugriff (PDF)

The enduring centrality of dopamine in the pathophysiology of schizophrenia: in vivo evidence from the prodrome to the first psychotic episode

Advances in pharmacology (1990), 2013, Vol.68, p.199

2013

Volltextzugriff (PDF)

Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans

Translational psychiatry, 2017-02, Vol.7 (2), p.e1027-e1027

2017

Volltextzugriff (PDF)

1 – 25 von 177

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(167)
Mit Volltextzugriff
(145)

Sprache

Englisch
(176)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization

The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders

The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment

Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors

Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses

Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis

The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review

The impact of severe mental illness (SMI) on the rate of COVID-19 vaccine uptake and hesitancy

From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments

Making decisions about antipsychotics: a qualitative study of patient experience and the development of a decision aid

A comprehensive review and model of putative prodromal features of bipolar affective disorder

Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications

The practical management of refractory schizophrenia - the Maudsley Treatment REview and Assessment Team service approach

Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging

The Dopamine Hypothesis of Schizophrenia: Version III-The Final Common Pathway

Altered activation and connectivity in a hippocampal–basal ganglia–midbrain circuit during salience processing in subjects at ultra high risk for psychosis

Fronto-limbic engagement during moral processing in stimulant users

Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia

Striatal dopamine synthesis capacity in twins discordant for schizophrenia

Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia

Functional outcome in people at high risk for psychosis predicted by thalamic glutamate levels and prefronto-striatal activation

The Predictive Power of Brain mRNA Mappings for in vivo Protein Density: A Positron Emission Tomography Correlation Study

Presynaptic Dopaminergic Function: Implications for Understanding Treatment Response in Psychosis

The enduring centrality of dopamine in the pathophysiology of schizophrenia: in vivo evidence from the prodrome to the first psychotic episode

Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans

Aktive Filter

Suchergebnisse filtern